Marykutty^1*, Mariam²

{¹Assistant Professor, Department of Medicine} {²Associate Professor, Department of Psychiatry}

Government Medical College and Hospital, Bastar Dt. Jagdalpur Chhattisgarh, INDIA.

Email: valsala.dbs@gmail.com

REFERENCES

1. World Health Organization [home page on the internet]. c2008 [cited 2008 October 23].
2. Averting HIV and AIDS [home page on the internet]. 2008 November 26 [cited 2009 January 5]
3. Cooper CL, Breau C, Laroche A, Lee C, Garber G. Clinical outcomes of first antiretroviral regimen in HIV/hepatitis C virus co-infection. HIV Med 2006; 7(1): 32–37.
4. Bachani D. 650 link ART centres planned under NACP-III. NACO News 2009; 5(1): 8.
5. National AIDS Control Organization. Ministry of Health and Family Welfare, Government of India. [home page on the internet]. 2009 August 26 [cited 2009 August 31]. Available from: URL: https:// nacoonline.org/NACO
6. Retty Rajan Modayil , Anand Harugeri , Gurumurthy Parthasarathi . Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India. pharmacoepidemiology and drug safety 2010; 19: 247–255.
7. Szarfman, Ana, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Safety 2002; 25(6): 381-92.
8. Salazar AH, Rosales SPDL, Frausto SR, Criollo E, Dubon CA, Topete RO. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. Arch Med Res. 2006; 37(7): 899-902.
9. González-Martín G, Yañez CG, González-Contreras L, Labarca J. Adverse drug reactions (ADRs) in patients with HIV infection. A prospective study. Int J Clin Pharmacol Ther. 1999; 37(1): 34-40.
10. Manzardo C, Zaccarelli M, Agüero F, Antinori A, Miró JM. Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease. J Acquir Immune Defic Syndr. 2007; 46(1): S9-18.
11. Bates, David W, Cullen DJ, Laird N, Petersen LA, Small SD, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995: 274(1): 29-34.
12. Puro V, Cicalini S, Carli GD, Soldani F, Antunes F, Balslev U, et al. Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting. European Journal of epidemiology. 2004: 19(6): 577-84.
13. Calmy A, Hirschel B, Cooper DA, Carr A. A new era of antiretroviral drug toxicity. Antivir Ther. 2009; 14(2): 165-79.
14. Ramanjireddy Tatiparthi, Yitagesu Mamo. Prevalence of ADRs and Associated Factors of Antiretroviral Treatment on HIV Positive Adults at Jush. Indian Journal of Pharmacy Practice. Oct-Dec, 2014; 7(4): 8-15.